Vall d’Hebron continues pancreatic cancer drug trial following good results
0
19
The Vall d’Hebron Institute of Oncology (VHIO) is carrying out a phase II clinical trial international phase II clinical trial of a new drug, MSC-1, which has already yielded good results in a first stage with 41 patients in advanced cancers, among them of pancreas. The mission of the new drug is to. block the […]